As a research service provider of rare disease diagnostics, we focus on addressing unmet needs in this field. Our dedicated team combines extensive expertise and skills to provide breakthrough solutions for your rare disease diagnostic research.
Professional Knowledge and Experience
Continuous Tracking of Cutting-edge Technologies
Effective Teamwork and Communication
Comprehensive Support from Concept to Practice
Our antigen detection reagent/kit development service combines advanced technologies with meticulous research to deliver reliable and specific results.
Leveraging our expertise, we collaborate with you to design and produce highly sensitive and specific reagents and kits for detecting target antibodies.
Harnessing the power of molecular biology, our nucleic acid detection reagent/kit development service offers state-of-the-art solutions for detecting nucleic acids.
By leveraging our expertise in assay development and analytical chemistry, we can create tailored reagents and kits that enable the quantification and profiling of metabolites.
Using advanced molecular and immunological techniques, we develop reagents and kits that enable the sensitive and specific detection of bacteria, viruses, fungi, and parasites.
Cytogenetic Diagnostic Platforms
PCR Technology Platforms
Immunoassay Technology Platforms
Sequencing Technology Platforms
Metabolomics Diagnostic Platforms
With our team of skilled scientists and cutting-edge technology platforms, we offer one-stop solutions for rare disease diagnostic development, including IVD product development, point-of-care test development, and companion diagnostic development.
Our goal is to advance rare disease diagnostics and accelerate the path from diagnostic research to commercialization.
With our expertise in assay development and bioengineering, we work closely with you to design and manufacture IVD devices that adhere to the highest quality standards.
Our point-of-care test (POCT) development service focuses on developing rapid and user-friendly diagnostic solutions that can be performed at the point of patient care.
Leveraging our expertise in biomarker identification, assay development, and regulatory compliance to create companion diagnostics that provide actionable insights for targeted therapies.
At our company, we provide tailored solutions for the diagnosis of various rare diseases.
We specialize in the development of advanced nucleic acid testing kits and cutting-edge equipment to facilitate early detection of genetic diseases.
We develop rapid diagnostic kits and point-of-care diagnostic products to help quickly and accurately identify infectious sources.
For autoimmune diseases, we focus on developing biomarker tests and immunoassay products to accurately identify these complex diseases.
We develop metabolite detection kits and supporting devices to facilitate accurate assessment and precision treatment of metabolic diseases.
Please feel free to contact us for information about our services or to ask any questions you may have in your rare disease diagnostic research.
